Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elicera Therapeutics AB | 275,766 | net | 27 May 2025 | tx 17+5,534,766−5,259,000 |
| Annexin Pharmaceuticals via Annexin Incentive | 250,000 | net | 11 Mar 2019 | tx 5+250,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2025 | SALE | Elicera Therapeutics AB | 237,500 | 6.30 SEK | |
| 23 May 2025 | SALE | Elicera Therapeutics AB | 102,500 | 6.51 SEK | |
| 26 May 2025 | SALE | Elicera Therapeutics AB | 25,000 | 7.06 SEK | |
| 27 May 2025 | SALE | Elicera Therapeutics AB | 20,000 | 6.59 SEK | |
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 151,900 | 1.85 SEK | |
| 25 Apr 2024 | PURCHASE | Elicera Therapeutics AB | 50,000 | 1.00 SEK | |
| 20 Mar 2024 | SALE | Elicera Therapeutics AB | 2,687,000 | 1.28 SEK | |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 21,700 | 16.20 SEK | |
| 26 Feb 2024 | PURCHASE | Elicera Therapeutics AB | 64,500 | 0.02 SEK | derivfirst after silence |
| 04 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 31,000 | 0.01 SEK | derivanomaly |
| 01 Mar 2024 | SALE | Elicera Therapeutics AB | 500,000 | 0.00 SEK | deriv |
| 04 Mar 2024 | SALE | Elicera Therapeutics AB | 1,687,000 | 0.00 SEK | deriv |
| 08 Jul 2021 | OTHER | Elicera Therapeutics AB | 2,583,333 | 0.00 SEK | |
| 05 Jul 2021 | PURCHASE | Elicera Therapeutics AB | 23,000 | 4.30 SEK | first after silence |
| 10 Jun 2021 | LENDING | Elicera Therapeutics AB | 2,583,333 | 0.00 SEK | |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 13,000 | 0.00 SEK | deriv |
| 10 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 13,000 | 8.00 SEK | |
| 11 Mar 2019 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 38,452 | 1.59 SEK | |
| 29 May 2018 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 94,410 | 8.80 SEK | |
| 25 May 2018 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 94,410 | 8.80 SEK | |
| 24 May 2018 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 11,364 | 8.80 SEK | |
| 19 Mar 2018 | PURCHASE | Annexin Pharmaceuticals via Annexin Incentive | 11,364 | 0.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 26 Feb 2024.